House BillHR 4509Veterans' medical carePrescription drugs
NOPAIN for Veterans Act
INTRO JUL 17· LAST ACTION JAN 13
READING
2MIN
COSPONSORS
32BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
This bill addresses the critical issue of pain management, particularly for veterans, while also tackling the broader concern of opioid addiction. By requiring the VA to proactively include non-opioid pain medications in its official drug lists, it offers veterans more diverse and potentially safer options for pain relief.
If this bill becomes law, veterans could see a wider array of pain treatment choices, potentially reducing their exposure to opioids and the risks associated with them. If it doesn't pass, the availability of these specific non-opioid alternatives in the VA system might remain inconsistent or take longer to be adopted, potentially limiting choices for veterans seeking to manage pain without opioids.
KEY PROVISIONS
5AI-extracted
PROVISION 01
Defines "non-opioid pain management drug or biological product" as an FDA-approved drug for postoperative pain or regional analgesia that does not act on opioid receptors.
Establishes clear criteria for which non-opioid medications the VA must include.
PROVISION 02
Requires the VA Secretary to include eligible non-opioid pain management drugs in the VA's national formulary within one year of them qualifying for certain payment categories.
Ensures a timely process for adding new non-opioid options to the VA's approved drug list.
PROVISION 03
Mandates the inclusion of these non-opioid pain management drugs in the Department's drug standardization list.
Promotes consistent availability and use of these pain management options across all VA facilities.
PROVISION 04
Prohibits using funds from the Cost of War Toxic Exposures Fund to carry out the provisions of this bill.
Prevents diversion of funds intended for toxic exposure care to implement these pain management provisions.
PROVISION 05
Directs the VA Secretary to implement these changes within 90 days of the bill becoming law.
Sets a firm timeline for the VA to make these non-opioid pain medications available to veterans.
This bill addresses the critical issue of pain management, particularly for veterans, while also tackling the broader concern of opioid addiction. By requiring the VA to proactively include non-opioid pain medications in its official drug lists, it offers veterans more diverse and potentially safer options for pain relief.
If this bill becomes law, veterans could see a wider array of pain treatment choices, potentially reducing their exposure to opioids and the risks associated with them. If it doesn't pass, the availability of these specific non-opioid alternatives in the VA system might remain inconsistent or take longer to be adopted, potentially limiting choices for veterans seeking to manage pain without opioids.
KEY PROVISIONS
AI-extracted
high
Defines "non-opioid pain management drug or biological product" as an FDA-approved drug for postoperative pain or regional analgesia that does not act on opioid receptors.
Establishes clear criteria for which non-opioid medications the VA must include.
high
Requires the VA Secretary to include eligible non-opioid pain management drugs in the VA's national formulary within one year of them qualifying for certain payment categories.
Ensures a timely process for adding new non-opioid options to the VA's approved drug list.
med
Mandates the inclusion of these non-opioid pain management drugs in the Department's drug standardization list.
Promotes consistent availability and use of these pain management options across all VA facilities.
med
Prohibits using funds from the Cost of War Toxic Exposures Fund to carry out the provisions of this bill.
Prevents diversion of funds intended for toxic exposure care to implement these pain management provisions.
high
Directs the VA Secretary to implement these changes within 90 days of the bill becoming law.
Sets a firm timeline for the VA to make these non-opioid pain medications available to veterans.
Not later than one year after the date on which a non-opioid pain management drug or biological product becomes eligible for temporary additional payment under section 1833(t)(16)(G) of the Social Security Act (42 U.S.C. 1395l(t)(16)(G)), or eligible for separate payment under section 416.174 of title 42, Code of Federal Regulations (or successor regulation).
Secretary shall include non-opioid pain management drug or biological product in the national formulary of the Department.
Not later than 90 days after the date of the enactment of this Act.
The Secretary of Veterans Affairs shall implement the amendments made by this section.
GLOSSARY
AI-written
National Formulary
A list of prescription drugs covered by a health plan, like the Department of Veterans Affairs, which healthcare providers can prescribe to patients.
Non-opioid Pain Management Drug or Biological Product
A medication approved by the Food and Drug Administration (FDA) to reduce pain after surgery or provide regional pain relief without affecting the body's opioid receptors.
Postoperative Pain
Pain experienced by a patient after a surgical procedure.
Regional Analgesia
Pain relief provided to a specific area of the body, often used during or after surgery, without causing general numbness or unconsciousness.
Drug Standardization List
An internal list used by a healthcare system, such as the VA, to ensure consistency in the types and brands of medications available across its facilities.
Cost of War Toxic Exposures Fund
A specific fund within the Department of Veterans Affairs dedicated to providing healthcare and benefits to veterans exposed to toxic substances during their military service.
ACTION TIMELINE
4 EVENTS
JAN 13
Subcommittee Hearings Held
COMMITTEE
DEC 19, 25
Referred to the Subcommittee on Health.
COMMITTEE
JUL 17, 25
Introduced in House
INTROREFERRAL
JUL 17, 25
Referred to the House Committee on Veterans' Affairs.